TerminatedPHASE2, PHASE3NCT05111600
Open-label, Pivotal Clinical Trial to Confirm Efficacy and Safety of Autologous Grafts Containing Stem Cells Genetically Modified for Epidermis Restoration in Patients With Junctional Epidermolysis Bullosa
Studying Junctional epidermolysis bullosa
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Holostem s.r.l.
- Principal Investigator
- Cristina Magnoni, MD, SurgeonStruttura Complessa di Dermatologia Azienda Ospedaliero Universitaria Policlinico di Modena
- Intervention
- Transplantation(drug)
- Enrollment
- 2 enrolled
- Eligibility
- 65 years · All sexes
- Timeline
- 2022 – 2024
Study locations (2)
- Hopital Necker-Enfants Malades, Paris, France
- Struttura Complessa di Dermatologia Azienda Ospedaliero Universitaria Policlinico di Modena, Modena, Italy
Collaborators
IRCCS San Raffaele · University of Modena and Reggio Emilia
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05111600 on ClinicalTrials.govOther trials for Junctional epidermolysis bullosa
Additional recruiting or active studies for the same condition.